Nordicus Partners Corp. (NORD)

Investor overview

Latest News

21
June, 2023

NORDICUS PARTNERS CORPORATION TAKES A SIGNIFICANT EQUITY STAKE IN MAG MILE CAPITAL, INC.

Las Vegas, Nevada. June 21, 2023… Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company, specializing in providing Nordic and U.S. companies with the best possible conditions to establish themselves on the U.S. market, today announced it ente...
22
May, 2023

EKIMAS CORPORATION CHANGES NAME TO NORDICUS PARTNERS CORPORATION AND TICKER SYMBOL TO ‘NORD’

Las Vegas, Nevada., May 22, 2023... EKIMAS Corporation (OTC PINK: NORD) (“EKIMAS” or the “Company”), a financial consulting company specializing in providing Nordic companies with the best possible conditions to establish themselves on the U.S. market, today announced that its common stock began ...
Load more

Latest SEC Filing

FILING DATE:

November 13, 2023

Quarterly Report (Form 10-Q)

FILING DATE:

August 18, 2023

Quarterly Report (Form 10-Q)

Investor

FAQs

Nordicus Partners Corp. resides at 280 S. Beverly Drive, Suite 505, Beverly Hills, CA 90212.

Nordicus Partners Corp. was founded in 1993 under its original Company name; Cardiotech International, Inc.

The whole objective of Nordicus Partners Corp. is to be a publicly traded holding company, providing the right Nordic & U.S. companies with the opportunity and the means of getting established in the U.S.
Nordicus Partners Corp. works as a holding company.
The whole philosophy behind Nordicus Partners Corp. is to eliminate the fees that is usually reserved to investment managers, when you invest in traditional investment vehicles.
The organizational structure at Nordicus Partners Corp. ensures that the entire return accrues to the Nordicus Partners Corp. shareholders, thus maximizing your investment.

The Danish-based management company, Managementselskabet af 12.08.2020 A/S, is a wholly owned subsidiary to Nordicus Partners Corp.

Managementselskabet af 12.08.2020 A/S manages the holding company that is Nordicus Partners Corp.

Nordicus Partners Corp. went public in 1993 under its original name Cardiotech International, Inc. Mitsubishi Chemical Performance Polymers acquired AdvanSource Biomaterials Corporation (formerly Cardiotech International, Inc.) on January 31, 2020, which led to the company becoming a shell company with no operational activity. Conversely, the company changed its name to EKIMAS Corporation and later became Nordicus Partners Corp. as we know it today.

Nordicus Partners Corp. is currently listed on the OTC PINK Market, with the ticker symbol "NORD".

Nordicus Partners Corp. fiscal year ends on March 31.

Please contact a stockbroker, bank, or other institution that offers brokerage services to buy or sell Nordicus Partners Corp. common stock.

Please contact our Investor Relations department, using our contact form.

Nordicus Partners Corp. transfer agent is Transfer Online, Inc. They can be reached at the following addresses:

Website: https://transferonline.com/

E-mail inquiries: info@transferonline.com

Transfer Online, Inc.
512 SE Salmon St.
Portland, OR 97214

Please contact our transfer agent, Transfer Online, Inc., to make changes.

Nordicus Partners Corp. will issue a press release announcing each earnings date. In addition, a link to the webcast will also be made available on our website in our “News” section.

Nordicus Partners Corp. does not currently pay dividends.

Nordicus Partners Corp. independent registered public accounting firm is BFBorgers CPA PC.

Our legal counsel is Culhane Meadows Haughian & Walsh PLLC and Shumaker Mallory LLP.

Nordicus Partners Corp. Investor Relations department can provide information regarding financial performance and business strategy that is already made public.
You can contact Investor Relations through our contact page here.